Canaccord Genuity Maintains a 'Buy' on Meridian Biosciences (VIVO); Q3 Preview: Performing Well Despite Hurdles
Tweet Send to a Friend
Canaccord Genuity maintains a 'Buy' on Meridian Biosciences (NASDAQ: VIVO) price target of $25.00.
Analyst, Jeffrey Frelick, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Jeffrey Frelick, said, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
